| About NicOx | |||
| Products | |||
|
Naproxcinod NCX 6560 Full portfolio |
|||
| Maximizing portfolio | |||
| Co-development Research alliances Technology |
|||
| People | |||
|
Board of Directors Management Team Contacts Careers |
|||
| Investor & media | |||
| Press releases Investor relations Fact file Financials Corporate governance "Informations Réglementées" Conferences |
|||
| Home | |||
| Directions to NicOx Site en français |
|||
 |
Contacts at NicOx | ||
| Business development |
Gavin SPENCER Vice-President Business Development spencer@nicox.com |
||
|
|||
|
Finance and investor relations |
Karl HANKS Director of investor relations and Corporate Communications hanks@nicox.com |
|
|
|||
| Head office | NicOx S.A. Les Taissounières - 1681 Route des Dolines - Bat HB4 B.P. 313 06 906 Sophia Antipolis Cedex France nicox@nicox.com Tel: +33 (0)4 97 24 53 00 Fax: +33 (0)4 97 24 53 99 |
||
| Italian subsidiary | NicOx Research Institute SRL with sole member Via Ariosto 21 20091 Bresso (MI) Italy Capital stock € 1.000.000 Tax code 12906310151 Vat IT12906310151 Companies Register 12906310151 R.E.A. 1597457 nicox@nicox.com Tel: +39 02 61 03 61 Fax: +39 02 61 03 64 30 Fax laboratories: +39 02 61 03 62 30 |
||
| US Headquarters |
NicOx Inc. 15 Independence Blvd Warren Township, NJ 07059 - U.S. nicox@nicox.com Tel: +1 908 604 1070 Fax: +1 908 604 1076 |
||